Sideroblastic Anemia: Causes, Ringed Sideroblasts, and At-Risk Groups

Sideroblastic Anemia: Iron-Loaded Mitochondria in Erythroblasts

Sideroblastic anemias are a heterogeneous group of disorders characterized by defective heme synthesis, leading to iron accumulation in mitochondrial rings around the nucleus of erythroblasts (ringed sideroblasts).

Classification

  • Congenital: X-linked (ALAS2 mutations) – most common; autosomal recessive (SLC25A38, GLRX5).
  • Acquired: Myelodysplastic syndromes (MDS), drugs (isoniazid, linezolid, chloramphenicol), alcohol, lead, copper deficiency, zinc excess.
  • Idiopathic: Often MDS-related.

Clinical Features

  • Microcytic or dimorphic (mixed microcytic/normocytic) anemia.
  • Iron overload (high ferritin, transferrin saturation) despite anemia.
  • Symptoms: fatigue, hepatosplenomegaly, skin bronzing (if iron overload).

Demographics

Congenital forms present in childhood/young adulthood; acquired forms predominate in older adults (>60), slightly more common in males (X-linked).

Management

  • Remove offending agent (drug, alcohol).
  • Pyridoxine (B6) responsive in some ALAS2 mutations.
  • Chelation if iron overloaded.
  • Luspatercept for MDS-ringed sideroblast (MDS-RS) with transfusion dependence.

Blood Disorders - Related Articles